Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04808245 |
|---|---|
| Brief Title: | A MultIceNTER Phase I Peptide VaCcine Trial for the Treatment of H3-Mutated Gliomas (INTERCEPT-H3) |
| First Submitted : | March 5, 2021 |
| First Submitted that Met QC Criteria : | March 18, 2021 |
| First Posted : | March 22, 2021 |
| Last Update Submitted that Met QC Criteria : | April 4, 2024 |
| Last Update Posted : | April 5, 2024 |